Antagonization of monoamine reuptake transporters by agmatine improves anxiolytic and locomotive behaviors commensurate with fluoxetine and methylphenidate
Abstract Background Agmatine (AGM) is known for its protective effects including neuroprotection, nephroprotection, gastroprotection, cardioprotection, and glucoprotection. Studies have validated the neuroprotective role of AGM as antidepressant, anxiolytic, locomotive, and antipsychotic agent in ps...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
SpringerOpen
2021-04-01
|
| Sarja: | Beni-Suef University Journal of Basic and Applied Sciences |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s43088-021-00118-7 |